Report #2827356

Overview

Sex

Male

Age

42 yrs

State

NJ

Recovered

Unknown

Vaccinated

—

Onset

—

Days to onset

—

Hospital days

—

Symptoms (1)

Symptom narrative

3rd dose of Twinrix in less than the 6 months period from the second dose; This non-serious case was reported by a nurse via call center representative and described the occurrence of drug dose administration interval too short in a 42-year-old male patient who received HAB (Twinrix) for prophylaxis. Previously administered products included Twinrix (2nd dose received on an unknown date) and Twinrix (1st dose received on an unknown date). On an unknown date, the patient received the 3rd dose of Twinrix. On an unknown date, an unknown time after receiving Twinrix, the patient experienced drug dose administration interval too short (Verbatim: 3rd dose of Twinrix in less than the 6 months period from the second dose). The outcome of the drug dose administration interval too short was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 13-FEB-2025 Nurse called to report that a patient received 3 doses of Twinrix, but the 3dr dose was too close in less than 6 months from the second dose, which led shortening of vaccine schedule. The reporter asked was this dose valid. She has in her stock Engerix-B and Havrix, a dose of each one would be enough to complete the series. The reporter consented to follow up.